Polymorphisms at the Microseminoprotein-beta locus associated with physiologic variation in beta-microseminoprotein and prostate-specific antigen levels.

Polymorphisms at the Microseminoprotein-beta locus associated with physiologic variation in beta-microseminoprotein and prostate-specific antigen levels.

BACKGROUND: rs10993994, a single nucleotide polymorphism (SNP) at the genetic locus encoding beta-microseminoprotein (beta-MSP), is associated with both prostate cancer risk and levels of blood prostate-specific antigen (PSA), a biomarker used in prostate cancer screening. Therefore, we wished to de...

Full description

Bibliographic Details
Main Authors:	Xu, X, Valtonen-André, C, Sävblom, C, Halldén, C, Lilja, H, Klein, R
Format:	Journal article
Language:	English
Published:	2010

Similar Items

Beta-microseminoprotein in serum correlates with the levels in seminal plasma of young, healthy males.
by: Valtonen-André, C, et al.
Published: (2008)

A common prostate cancer risk variant 5' of microseminoprotein-beta (MSMB) is a strong predictor of circulating beta-microseminoprotein (MSP) levels in multiple populations.
by: Waters, K, et al.
Published: (2010)

Levels of beta-microseminoprotein in blood and risk of prostate cancer in multiple populations.
by: Haiman, C, et al.
Published: (2013)

Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer.
by: Liisa Sjöblom, et al.
Published: (2016-01-01)

beta-Microseminoprotein binds CRISP-3 in human seminal plasma.
by: Udby, L, et al.
Published: (2005)

Correction: Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer.
by: PLOS ONE Staff
Published: (2016-01-01)

Urinary prostate-specific antigen and microseminoprotein-beta levels in men with and without prostate cancer: A prospective cohort study
by: Prashant Shrivastava, et al.
Published: (2020-01-01)

β-Microseminoprotein binds CRISP-3 in human seminal plasma
by: Udby, L, et al.
Published: (2005)

Association of cysteine-rich secretory protein 3 and beta-microseminoprotein with outcome after radical prostatectomy.
by: Bjartell, A, et al.
Published: (2007)

The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine
by: Whitaker, H, et al.
Published: (2010)

The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine.
by: Hayley C Whitaker, et al.
Published: (2010-10-01)

The role of plasma microseminoprotein-beta in prostate cancer: an observational nested case-control and Mendelian randomization study in the European prospective investigation into cancer and nutrition
by: Smith Byrne, K, et al.
Published: (2019)

The Ubiquitin-Proteasome System Does Not Regulate the Degradation of Porcine β-Microseminoprotein during Sperm Capacitation
by: Lucie Tumova, et al.
Published: (2020-06-01)

Association between polymorphisms in the prostate-specific antigen (PSA) promoter and release of PSA.
by: Sävblom, C, et al.
Published: (2009)

β-Microseminoprotein endows post coital seminal plasma with potent candidacidal activity by a calcium- and pH-dependent mechanism.
by: Anneli M L Edström Hägerwall, et al.
Published: (2012-01-01)

Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men.
by: Klein, R, et al.
Published: (2012)

Variation in percentage-free prostate-specific antigen (PSA) with prostate volume, age and total PSA level.
by: Törnblom, M, et al.
Published: (2001)

The evolution of the glandular kallikrein locus: identification of orthologs and pseudogenes in the cotton-top tamarin.
by: Olsson, A, et al.
Published: (2004)

Biology of prostate-specific antigen
by: Lilja, H
Published: (2003)

Biology of prostate-specific antigen.
by: Lilja, H
Published: (2003)

Genetic polymorphisms of estrogen receptors alpha and beta and the risk of developing prostate cancer.
by: Young Kwang Chae, et al.
Published: (2009-08-01)

Assessment of intra-individual variation in prostate-specific antigen levels in a biennial randomized prostate cancer screening program in Sweden.
by: Bruun, L, et al.
Published: (2005)

An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection.
by: Vickers, A, et al.
Published: (2011)

TCR beta polymorphisms and multiple sclerosis.
by: Dyment, D, et al.
Published: (2004)

Intergenic transcription and transinduction of the human beta-globin locus.
by: Ashe, H, et al.
Published: (1997)

Allelic sequence diversity at the human beta-globin locus
by: Fullerton, S, et al.
Published: (1994)

Comprehensive assessment of variation at the transforming growth factor beta type 1 receptor locus and colorectal cancer predisposition.
by: Carvajal-Carmona, L, et al.
Published: (2010)

Prostate-specific antigen and prostate cancer: prediction, detection and monitoring.
by: Lilja, H, et al.
Published: (2008)

Polymorphic variation in the 11beta-hydroxylase gene associates with reduced 11-hydroxylase efficiency.
by: Barr, M, et al.
Published: (2007)

Innate Variability in Physiological and Omics Aspects of the Beta Thalassemia Trait-Specific Donor Variation Effects
by: Alkmini T. Anastasiadi, et al.
Published: (2022-06-01)

Early prostate-specific antigen changes and the diagnosis and prognosis of prostate cancer.
by: Botchorishvili, G, et al.
Published: (2009)

Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancer.
by: Vickers, A, et al.
Published: (2009)

[Isoforms of free prostate-specific antigen]
by: Haese, A, et al.
Published: (2004)

Isoforms of free prostate-specific antigen
by: Haese, A, et al.
Published: (2004)

Erratum: Variation in percentage-free prostate-specific antigen (PSA) with prostate volume, age and total PSA level (British Journal of Urology International 87 (638-642))
by: Törnblom, M, et al.
Published: (2001)

Blood biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms: kallikreins and prostate cancer.
by: Klein, R, et al.
Published: (2010)

Polymorphisms within the novel type 2 diabetes risk locus MTNR1B determine beta-cell function.
by: Harald Staiger, et al.
Published: (2008-01-01)

Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer.
by: Denmeade, SR, et al.
Published: (2003)

On the use of prostate-specific antigen for screening of prostate cancer in European Randomised Study for Screening of Prostate Cancer.
by: Bangma, C, et al.
Published: (2010)

Prostate-specific antigen and related isoforms in the diagnosis and management of prostate cancer.
by: Haese, A, et al.
Published: (2004)